Skip to main content
SI-BONE, Inc. logo

SI-BONE, Inc. — Investor Relations & Filings

Ticker · SIBN ISIN · US8257041090 LEI · 549300J8JGYVJJHV9C31 US Manufacturing
Open in API
Filings indexed 705 across all filing types
Latest filing 2018-09-20 Regulatory Filings
Country US United States of America
Listing US SIBN

About SI-BONE, Inc.

https://si-bone.com/

SI-BONE, Inc. is a medical device company that develops solutions for musculoskeletal disorders of the sacropelvic anatomy. The company pioneered the minimally invasive surgical (MIS) treatment of sacroiliac (SI) joint dysfunction, a common cause of chronic lower back pain, with its proprietary iFuse Implant System. The iFuse system is designed for sacroiliac joint fusion and stabilization. SI-BONE has expanded its portfolio to address other sacropelvic conditions, including pelvic fractures and instability, utilizing technologies such as 3D-printed implants. The company focuses on advancing the diagnostic understanding and surgical treatment of these often under-diagnosed and under-treated orthopedic conditions.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2018
Regulatory Filings Classification · 100% confidence The document is a correspondence letter from the company's legal counsel to the SEC addressing comments on a Draft Registration Statement on Form S-1. It discusses responses to SEC staff comments related to the company's registration for an initial public offering. The document references the Form S-1 registration statement and is a response to regulatory review comments, not a financial report or earnings release. It is not a report itself but a regulatory filing correspondence related to the registration process. Therefore, it fits best under Regulatory Filings (RNS).
2018-09-20 English
FORM S-1
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission. It is a detailed registration statement for an initial public offering (IPO) of common stock by SI-BONE, Inc. The text includes information about the offering, company business, risk factors, financial data, management discussion, and other disclosures typical of an S-1 filing. This type of document is related to capital raising and financing activities, specifically the registration of securities for public sale. Therefore, it fits the category of Capital/Financing Update (CAP). The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or a certification, so it is not RPA or RNS. Hence, the correct classification is CAP with high confidence.
2018-09-20 English
Regulatory Filings 2018
Regulatory Filings
2018-08-28 English
Capital/Financing Update 2018
Capital/Financing Update Classification · 100% confidence The document is a confidential draft registration statement submitted to the U.S. Securities and Exchange Commission on Form S-1, which is used for initial public offerings (IPOs). It includes detailed information about the company, SI-BONE, Inc., its business, financial data, risk factors, management, and underwriting details. The presence of the Form S-1 and the context of an IPO registration clearly indicate this is a capital raising filing. According to the filing definitions, updates on company fundraising or capital structure changes fall under Capital/Financing Update (CAP). This document is not an annual report, earnings release, or any other report type but a registration statement for securities offering, which fits best under CAP.
2018-07-31 English
Regulatory Filings 2017
Regulatory Filings Classification · 100% confidence The document is a letter from the company's legal counsel responding to comments from the SEC staff regarding an Amendment No. 2 to a Draft Registration Statement on Form S-1. It discusses detailed responses to SEC comments on various disclosures in the draft registration statement, including risk factors, capitalization, dilution, market share, sales and marketing expenses, manufacturing agreements, principal stockholders, stock option plans, and earnings per share calculations. The document is not the registration statement itself but a comment letter addressing the SEC's review comments on the draft registration statement. Such comment letters are regulatory correspondence related to the registration process and do not constitute the actual registration statement or financial report. Therefore, this document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory correspondence and filings that do not fit other specific categories.
2017-05-24 English
Capital/Financing Update 2017
Capital/Financing Update Classification · 95% confidence The document is a confidential draft registration statement (Form S-1) submitted to the U.S. Securities and Exchange Commission for SI-BONE, Inc. It is a registration statement under the Securities Act of 1933, indicating an initial public offering (IPO) of common stock. The document includes detailed information typical of an IPO prospectus, such as business description, risk factors, financial data, management discussion, and underwriting details. This type of filing is a registration statement for securities offering, which falls under the category of Capital/Financing Update (CAP) because it relates to the company's fundraising and capital raising activities through an IPO. It is not an annual report, earnings release, or other types of filings. Therefore, the correct classification is CAP with high confidence.
2017-05-24 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.